Sector portfolio · VC firm · United Kingdom
Future Planet Capital's Biotech portfolio
Future Planet Capital has backed 16 Biotech startups in rounds we track, $394M between them, shown by the stage each has reached. The best-funded is Nuclera.
Future Planet Capital's whole portfolioFuture Planet Capital's profile
Funding by segment
- Stage not reported$28M6
- Pre-seed and seed$59M5
- Series C and later$192M3
- Series B$115M2
Where they are based
- United Kingdom15$354M
- United States1$40M
United Kingdom
United StatesFounded
2 without a founding year on record.
Total raised
- Under $1M2
- $1M to $10M5
- $10M to $50M6
- $50M to $250M3
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
14 of 16 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United Kingdom15
- United States1
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
6 startups · $28M raised
MitoRx TherapeuticsMitoRx Therapeutics is a preclinical-stage biotechnology company based in Oxford, UK.United Kingdom$13M
AMLo BiosciencesAMLo Biosciences is a UK-based HealthTech and medical device company founded in late 2017.United Kingdom$7.1M
Linear DiagnosticsLinear Diagnostics Limited is a diagnostics company based on a novel technologyUnited Kingdom$3.2M
Laverock TherapeuticsLaverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.United Kingdom$3.0M
Bitrobius GeneticsBitrobius Genetics is a developer of a DNA transfer technology designed to revolutionize gene and cancer therapy.United Kingdom$945K
ZentraxaZentraxa Limited is a biotechnology and engineering biology company based in Bristol, England.United Kingdom$386K
Pre-seed and seed
5 startups · $59M raised
NanoSyrinxNanoSyrinx is a UK-based synthetic biology company focused on developing a novel drug delivery platform called Nanosyringes.United Kingdom$26M- ODOrbit DiscoveryUnited Kingdom$17M
IkarovecIkarovec Limited is a UK-based biotechnology company focused on developing novel bicistronic gene therapies for chronic eye diseasUnited Kingdom$10M
MFXMFX provides digital financial services.United Kingdom$4.0M
NK:IONK:IO is a London-based biotech company and a spinout from Imperial College London, focused on developing innovative therapies forUnited Kingdom$1.5M
Series C and later
3 startups · $192M raised
NucleraNuclera is a biotechnology company focused on making proteins more accessible to enhance drug discovery, proteomics, and life scieUnited Kingdom$95M
SynthaceSynthace is a London-based life sciences software company founded in 2011.United Kingdom$64M
Eagle GenomicsEagle Genomics is a TechBio company based at the Wellcome Genome Campus in Cambridge, UK.United Kingdom$33M
Series B
2 startups · $115M raised
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Future Planet Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Future Planet Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.